Replicel Life Sciences Inc (RP.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Operating Expenses | 1,094 | 1,299 | 1,178 | 1,366 | 1,204 |
| Operating Income | -1,094 | -1,299 | -1,178 | -1,366 | -1,204 |
| Other Income | 25 | -1 | -6 | 4 | 6 |
| Pre-tax Income | -1,070 | -1,300 | -1,184 | -1,362 | -1,198 |
| Net Income Continuous | -1,070 | -1,300 | -1,184 | -1,362 | -1,198 |
| Net Income | $-1,070 | $-1,300 | $-1,184 | $-1,362 | $-1,198 |
| EPS Basic Total Ops | -0.20 | -0.20 | -0.20 | -0.30 | -0.20 |
| EPS Basic Continuous Ops | -0.20 | -0.20 | -0.20 | -0.30 | -0.20 |
| EPS Diluted Total Ops | -0.20 | -0.20 | -0.20 | -0.30 | -0.20 |
| EPS Diluted Continuous Ops | -0.20 | -0.20 | -0.20 | -0.30 | -0.20 |
| EBITDA(a) | $-1,093 | $-1,297 | $-1,177 | $-1,364 | $-1,202 |